EMGE / Emergent Health Corp - SEC-arkiveringar, Årsredovisning, Fullmaktsutlåtande

Emergent Health Corp
US ˙ OTCPK

Grundläggande statistik
CIK 1463459
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Emergent Health Corp
SEC Filings (Chronological Order)
Denna sida innehåller en komplett, kronologisk lista över SEC-arkiveringar, exklusive ägande-arkiveringar som vi tillhandahåller på andra ställen.
February 7, 2023 253G2

Offering Circular Supplement No.2 Dated February 6, 2023 Post-Qualification Offering Circular Amendment No. 1 dated January 4, 2023 EMERGENT HEALTH CORP. 800,000,000 Shares of Common Stock

Filed Pursuant to Rule 253(g)(2) File No. 024-11898 Offering Circular Supplement No.2 Dated February 6, 2023 to Post-Qualification Offering Circular Amendment No. 1 dated January 4, 2023 EMERGENT HEALTH CORP. 800,000,000 Shares of Common Stock This Offering Circular Supplement No. 2 (the “Supplement”) supplements our Post-Qualification Offering Circular Amendment No. 1 dated January 4, 2023 (the “

January 12, 2023 253G1

Emergent Health Corp. 800,000,000 Shares of Common Stock

Filed Pursuant to Rule 253(g)(1) File No. 024-11708 OFFERING CIRCULAR Emergent Health Corp. 800,000,000 Shares of Common Stock This Post-Qualification Offering Circular Amendment No. 2 (the “PQA2”) amends the Offering Statement of Emergent Health Corp., a Wyoming corporation (the “Company”), qualified on November 25, 2021, and as amended on November 10, 2022, and qualified on November 18, 2022, an

January 5, 2023 CORRESP

Emergent Health Corp. 150 Motor Parkway, Suite 401 Hauppauge, New York 11787

CORRESP 1 filename1.htm Emergent Health Corp. 150 Motor Parkway, Suite 401 Hauppauge, New York 11787 January 5, 2023 VIA EDGAR Ms. Jennie Beysolow Office of Trade & Services Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Emergent Health Corp. (the “Company”) Offering Statement on Form 1-A Post-qualification Amendment No. 2 (the “Pos

January 3, 2023 PART II AND III

Emergent Health Corp. 800,000,000 Shares of Common Stock

Post-Qualification Offering Circular Amendment No. 2 File No. 024-11708 OFFERING CIRCULAR Emergent Health Corp. 800,000,000 Shares of Common Stock This Post-Qualification Offering Circular Amendment No. 2 (the “PQA2”) amends the Offering Statement of Emergent Health Corp., a Wyoming corporation (the “Company”), qualified on November 25, 2021, and as amended on November 10, 2022, and qualified on N

January 3, 2023 EX1A-12 OPN CNSL

NEWLAN LAW FIRM, PLLC 2201 Long Prairie Road – Suite 107-762 Flower Mound, Texas 75022 January 3, 2023

Exhibit 12.1 NEWLAN LAW FIRM, PLLC 2201 Long Prairie Road – Suite 107-762 Flower Mound, Texas 75022 940-367-6154 January 3, 2023 Emergent Health Corp. 150 Motor Parkway, Suite 401 Hauppauge, New York 11787 Re: Offering Statement on Form 1-A Gentlemen: We have been requested by Emergent Health Corp., a Wyoming corporation (the “Company”), to furnish you with our opinion as to the matters hereinafte

January 3, 2023 EX1A-4 SUBS AGMT

SUBSCRIPTION AGREEMENT Emergent Health Corp. NOTICE TO INVESTORS

EX1A-4 SUBS AGMT 4 ex4-1.htm Exhibit 4.1 SUBSCRIPTION AGREEMENT Emergent Health Corp. NOTICE TO INVESTORS The securities of Emergent Health Corp., a Wyoming corporation (the “Company”), to which this Subscription Agreement relates, represent an investment that involves a high degree of risk, suitable only for persons who can bear the economic risk for an indefinite period of time and who can affor

January 3, 2023 EX1A-1 UNDR AGMT

1

Exhibit 1.1 1 2 3 4 5 6

December 22, 2022 EX1A-12 OPN CNSL

NEWLAN LAW FIRM, PLLC 2201 Long Prairie Road – Suite 107-762 Flower Mound, Texas 75022 December 22, 2022

Exhibit 12.1 NEWLAN LAW FIRM, PLLC 2201 Long Prairie Road ? Suite 107-762 Flower Mound, Texas 75022 940-367-6154 December 22, 2022 Emergent Health Corp. 150 Motor Parkway, Suite 401 Hauppauge, New York 11787 Re: Offering Statement on Form 1-A Gentlemen: We have been requested by Emergent Health Corp., a Wyoming corporation (the ?Company?), to furnish you with our opinion as to the matters hereinaf

December 22, 2022 PART II AND III

Emergent Health Corp. 800,000,000 Shares of Common Stock

PART II AND III 2 emgerega.htm Post-Qualification Offering Circular Amendment No. 2 File No. 024-11708 OFFERING CIRCULAR Emergent Health Corp. 800,000,000 Shares of Common Stock This Post-Qualification Offering Circular Amendment No. 2 (the “PQA2”) amends the Offering Statement of Emergent Health Corp., a Wyoming corporation (the “Company”), qualified on November 25, 2021, and as amended on Novemb

December 22, 2022 EX1A-1 UNDR AGMT

1

Exhibit 1.1 1 2 3 4 5 6

December 22, 2022 EX1A-4 SUBS AGMT

SUBSCRIPTION AGREEMENT Emergent Health Corp. NOTICE TO INVESTORS

Exhibit 4.1 SUBSCRIPTION AGREEMENT Emergent Health Corp. NOTICE TO INVESTORS The securities of Emergent Health Corp., a Wyoming corporation (the “Company”), to which this Subscription Agreement relates, represent an investment that involves a high degree of risk, suitable only for persons who can bear the economic risk for an indefinite period of time and who can afford to lose their entire invest

November 23, 2022 253G1

Emergent Health Corp. 300,000,000 Shares of Common Stock

Filed Pursuant to Rule 253(g)(1) File No. 024-11708 OFFERING CIRCULAR Emergent Health Corp. 300,000,000 Shares of Common Stock This Post-Qualification Offering Circular Amendment No. 1 (the “PQA”) amends the Offering Statement of Emergent Health Corp., a Wyoming corporation (the “Company”), qualified on November 25, 2021, and as may be amended and supplemented from time to time, to: (a) add 200,00

November 18, 2022 CORRESP

Emergent Health Corp. 150 Motor Parkway, Suite 401 Hauppauge, New York 11787

CORRESP 1 filename1.htm Emergent Health Corp. 150 Motor Parkway, Suite 401 Hauppauge, New York 11787 November 18, 2022 VIA EDGAR Ms. Jennie Beysolow Office of Trade & Services Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Emergent Health Corp. (the “Company”) Offering Statement on Form 1-A Post-qualification Amendment No. 1 (the “P

November 10, 2022 EX1A-7 ACQ AGMT

EX1A-7 ACQ AGMT

Exhibit 7.2

November 10, 2022 EX1A-7 ACQ AGMT

EX1A-7 ACQ AGMT

Exhibit 7.3

November 10, 2022 EX1A-6 MAT CTRCT

EX1A-6 MAT CTRCT

Exhibit 6.17

November 10, 2022 EX1A-6 MAT CTRCT

EX1A-6 MAT CTRCT

Exhibit 6.13

November 10, 2022 EX1A-6 MAT CTRCT

EX1A-6 MAT CTRCT

Exhibit 6.15

November 10, 2022 EX1A-2A CHARTER

EX1A-2A CHARTER

EX1A-2A CHARTER 4 ex2112.htm Exhibit 2.11.2

November 10, 2022 EX1A-6 MAT CTRCT

EX1A-6 MAT CTRCT

EX1A-6 MAT CTRCT 7 ex612.htm Exhibit 6.12

November 10, 2022 EX1A-6 MAT CTRCT

EX1A-6 MAT CTRCT

Exhibit 6.11

November 10, 2022 EX1A-7 ACQ AGMT

EX1A-7 ACQ AGMT

EX1A-7 ACQ AGMT 15 ex71.htm Exhibit 7.1

November 10, 2022 EX1A-6 MAT CTRCT

EX1A-6 MAT CTRCT

EX1A-6 MAT CTRCT 14 ex619.htm Exhibit 6.19

November 10, 2022 EX1A-6 MAT CTRCT

EX1A-6 MAT CTRCT

Exhibit 6.14

November 10, 2022 EX1A-12 OPN CNSL

NEWLAN LAW FIRM, PLLC 2201 Long Prairie Road – Suite 107-762 Flower Mound, Texas 75022 November 10, 2022

EX1A-12 OPN CNSL 18 ex12-1.htm NEWLAN LAW FIRM, PLLC 2201 Long Prairie Road – Suite 107-762 Flower Mound, Texas 75022 940-367-6154 November 10, 2022 Emergent Health Corp. 150 Motor Parkway, Suite 401 Hauppauge, New York 11787 Re: Offering Statement on Form 1-A Gentlemen: We have been requested by Emergent Health Corp., a Wyoming corporation (the “Company”), to furnish you with our opinion as to th

November 10, 2022 EX1A-6 MAT CTRCT

EX1A-6 MAT CTRCT

Exhibit 6.18

November 10, 2022 EX1A-6 MAT CTRCT

EX1A-6 MAT CTRCT

Exhibit 6.16

November 10, 2022 EX1A-2A CHARTER

EX1A-2A CHARTER

EX1A-2A CHARTER 3 ex2111.htm Exhibit 2.11.1

November 10, 2022 PART II AND III

Emergent Health Corp. 300,000,000 Shares of Common Stock

PART II AND III 2 emgerega.htm Post-Qualification Offering Circular Amendment No. 1 File No. 024-11708 OFFERING CIRCULAR Emergent Health Corp. 300,000,000 Shares of Common Stock This Post-Qualification Offering Circular Amendment No. 1 (the “PQA”) amends the Offering Statement of Emergent Health Corp., a Wyoming corporation (the “Company”), qualified on November 25, 2021, and as may be amended and

November 10, 2022 EX1A-6 MAT CTRCT

EX1A-6 MAT CTRCT

Exhibit 6.10

November 19, 2021 253G1

Emergent Health Corp. 100,000,000 Shares of Common Stock

253G1 1 emge253g1.htm Filed Pursuant to Rule 253 (g) (1) File No. 024-11708 OFFERING CIRCULAR Emergent Health Corp. 100,000,000 Shares of Common Stock By this Offering Circular, Emergent Health Corp., a Wyoming corporation, is offering for sale a maximum of 100,000,000 shares of its common stock (the “Offered Shares”), at a fixed price of $ 0.01 per share, pursuant to Tier 1 of Regulation A of the

November 16, 2021 CORRESP

EMERGENT HEALTH CORP. 20138 Valley Forge Circle King of Prussia, Pennsylvania 19406

EMERGENT HEALTH CORP. 20138 Valley Forge Circle King of Prussia, Pennsylvania 19406 November 15, 2021 VIA EDGAR Ryan Lichtenfels, Attorney Adviser Office of Trade & Services Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Emergent Health Corp. Offering Statement on Form 1-A Commission File No. 024-11708 Dear Mr. Lichtenfels: On behal

November 5, 2021 EX1A-2A CHARTER

EXHIBIT 2.1

EX1A-2A CHARTER 3 ex21.htm EXHIBIT 2.1 Exhibit 2.1

November 5, 2021 EX1A-12 OPN CNSL

EXHIBIT 12.1

EX1A-12 OPN CNSL 25 ex121.htm EXHIBIT 12.1 Exhibit 12.1

November 5, 2021 EX1A-6 MAT CTRCT

EXHIBIT 6.7

Exhibit 6.7

November 5, 2021 EX1A-6 MAT CTRCT

EXHIBIT 6.4

Exhibit 6.4

November 5, 2021 EX1A-2A CHARTER

EXHIBIT 2.8

EX1A-2A CHARTER 10 ex28.htm EXHIBIT 2.8 Exhibit 2.8

November 5, 2021 EX1A-6 MAT CTRCT

EXHIBIT 6.5

EX1A-6 MAT CTRCT 20 ex65.htm EXHIBIT 6.5 Exhibit 6.5

November 5, 2021 EX1A-2A CHARTER

EXHIBIT 2.9

EX1A-2A CHARTER 11 ex29.htm EXHIBIT 2.9 Exhibit 2.9

November 5, 2021 EX1A-4 SUBS AGMT

EXHIBIT 4.1

EX1A-4 SUBS AGMT 15 ex41.htm EXHIBIT 4.1 Exhibit 4.1

November 5, 2021 EX1A-2A CHARTER

EXHIBIT 2.10

Exhibit 2.10

November 5, 2021 EX1A-2A CHARTER

EXHIBIT 2.4

EX1A-2A CHARTER 6 ex24.htm EXHIBIT 2.4 Exhibit 2.4

November 5, 2021 EX1A-6 MAT CTRCT

EXHIBIT 6.1

EX1A-6 MAT CTRCT 16 ex61.htm EXHIBIT 6.1 Exhibit 6.1

November 5, 2021 EX1A-6 MAT CTRCT

EXHIBIT 6.3

Exhibit 6.3

November 5, 2021 EX1A-6 MAT CTRCT

EXHIBIT 6.8

EX1A-6 MAT CTRCT 23 ex68.htm EXHIBIT 6.8 Exhibit 6.8

November 5, 2021 EX1A-2A CHARTER

EXHIBIT 2.2

Exhibit 2.2

November 5, 2021 PART II AND III

As filed with the Securities and Exchange Commission on November ___, 2021 PART II - INFORMATION REQUIRED IN OFFERING CIRCULAR

File No. 024- As filed with the Securities and Exchange Commission on November , 2021 PART II - INFORMATION REQUIRED IN OFFERING CIRCULAR Preliminary Offering Circular dated November , 2021 An offering statement pursuant to Regulation A relating to these securities has been filed with the United States Securities and Exchange Commission (the “SEC”). Information contained in this Preliminary Offeri

November 5, 2021 EX1A-2B BYLAWS

EXHIBIT 2.12

EX1A-2B BYLAWS 14 ex212.htm EXHIBIT 2.12 Exhibit 2.12

November 5, 2021 EX1A-2A CHARTER

EXHIBIT 2.5

Exhibit 2.5

November 5, 2021 EX1A-2A CHARTER

EXHIBIT 2.3

EX1A-2A CHARTER 5 ex23.htm EXHIBIT 2.3 Exhibit 2.3

November 5, 2021 EX1A-6 MAT CTRCT

EXHIBIT 6.9

EX1A-6 MAT CTRCT 24 ex69.htm EXHIBIT 6.9 Exhibit 6.9

November 5, 2021 EX1A-6 MAT CTRCT

EXHIBIT 6.6

EX1A-6 MAT CTRCT 21 ex66.htm EXHIBIT 6.6 Exhibit 6.6

November 5, 2021 EX1A-6 MAT CTRCT

EXHIBIT 6.2

Exhibit 6.2

November 5, 2021 EX1A-2A CHARTER

EXHIBIT 2.6

Exhibit 2.6

November 5, 2021 EX1A-2A CHARTER

EXHIBIT 2.7

EX1A-2A CHARTER 9 ex27.htm EXHIBIT 2.7 Exhibit 2.7

November 5, 2021 EX1A-2A CHARTER

EXHIBIT 2.11

Exhibit 2.11

September 18, 2015 EX-10

EMPLOYMENT, NON-COMPETITION AND PROPRIETARY RIGHTS AGREEMENT

EXHIBIT 10.1 EMPLOYMENT, NON-COMPETITION AND PROPRIETARY RIGHTS AGREEMENT THIS EMPLOYMENT NON-COMPETITION AND PROPRIETARY RIGHTS AGREEMENT (the ?Agreement?) is effective as of the 17th day of June, 2015 (the ?Effective Date?), by and between Emergent Health Corp, a Nevada corporation (the ?Company?), and Chris Swenson (the ?Employee?). RECITALS: A. The Company is engaged in the sale of nutraceutic

September 18, 2015 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 June 18, 2015 Date of Report (Date of earliest event reported) EMERGENT HEALTH CORP.

September 18, 2015 RW

September 18, 2015

September 18, 2015 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Att: Pamala Howell Ronald E .

February 12, 2015 EX-10.10

EX-10.10

License Agreement EXHIBIT 10.10

February 12, 2015 EX-10.5

EX-10.5

Employment Agreement EXHIBIT 10.5

February 12, 2015 EX-10.12

EX-10.12

Promissory Note EXHIBIT 10.12

February 12, 2015 EX-10.11

EX-10.11

Securities Pledge Agreement EXHIBIT 10.11

February 12, 2015 S-1

EMGE / Emergent Health Corp. S-1 - Registration Statement - REGISTRATION STATEMENT

S-1 1 emergents1.htm REGISTRATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Emergent Health Corp. (Exact name of registrant as specified in its charter) Nevada 5122 20-8944630 (State or other jurisdiction of incorporation) (Primary Standard Industrial Classification Code Number) (I.R.S. Employe

February 12, 2015 EX-10.7

EX-10.7

Consulting Agreement EXHIBIT 10.7

February 12, 2015 EX-4.1

EMERGENT HEALTH CORP. CONVERTIBLE PROMISSORY NOTE

FORM OF CONVERTIBLE PROMISSORY NOTE EXHIBIT 4.1 EMERGENT HEALTH CORP. CONVERTIBLE PROMISSORY NOTE Company: Emergent Health Corp. Maturity Date: Twenty Four months from the date of issuance Principal Amount: $ Interest Rate: 12.0% per annum payable in full on the Maturity Date Conversion Rate: $0.75 per share or as adjusted Emergent Health Corp., a Nevada corporation, and any successor or resulting

February 12, 2015 EX-3.1

EX-3.1

Articles of Incorporation EXHIBIT 3.1

February 12, 2015 EX-10.2

EX-10.2

Consulting Agreement EXHIBIT 10.2

February 12, 2015 EX-10.6

EX-10.6

Stock Purchase Agreement EXHIBIT 10.6

February 12, 2015 EX-4.2

EX-4.2

Form of Warrant EXHIBIT 4.2

February 12, 2015 EX-10.3

EX-10.3

Consulting Agreement EXHIBIT 10.3

February 12, 2015 EX-3.2

EX-3.2

By-Laws EXHIBIT 3.2

February 12, 2015 EX-10.9

EX-10.9

Employment Agreement EXHIBIT 10.9

February 12, 2015 EX-10.13

EX-10.13

Assignment of Securities Pledge Agreement EXHIBIT 10.13

February 12, 2015 EX-10.1

EX-10.1

Employment Agreement EXHIBIT 10.1

February 12, 2015 EX-10.15

EX-10.15

Securities Purchase Agreement EXHIBIT 10.15

February 12, 2015 EX-10.4

EX-10.4

Consulting Agreement EXHIBIT 10.4

February 12, 2015 EX-10.8

EX-10.8

Promissory Note EXHIBIT 10.8

February 12, 2015 EX-10.14

EX-10.14

Extension of Promissory Note EXHIBIT 10.14

June 5, 2012 8-K

Other Events -

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2012 Emergent Health Corp. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation or organization) Commission File No. 0

January 17, 2012 8-K

Other Events -

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 31, 2011 Emergent Health Corp. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation or organization) Commission File No

November 2, 2011 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2011 Emergent Health Corp. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation or organization) Commission File No.

October 12, 2011 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 12, 2011 Emergent Health Corp. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation or organization) Commission File No.

July 11, 2011 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2011 Emergent Health Corp. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation or organization) Commission File No. 00

June 14, 2011 RW

EMERGENT HEALTH CORP

EMERGENT HEALTH CORP June 14, 2011 RW Filed Via EDGAR U.S. Securities and Exchange Commission 100 F Street N.E. Washington D.C. 20549 Attention: Attorneys Erin Wilson and James Lopez Re: Request to Withdraw Emergent Health Corp. Form 10 Filed May 16, 2011 File No. 000-54404 Ladies and Gentlemen: Emergent Health Corp. (the "Company") is herewith making an application to immediately request withdraw

June 8, 2011 8-K

Entry into a Material Definitive Agreement, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 8, 2011 Emergent Health Corp. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation or organization) Commission File No. 000

May 26, 2011 8-K

Entry into a Material Definitive Agreement, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2011 Emergent Health Corp. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation or organization) Commission File No. 000

May 16, 2011 10-12G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 10 GENERAL FORM FOR REGISTRATION OF SECURITIES OF SMALL BUSINESS ISSUERS Under Section 12(b) or 12(g) of the Securities Exchange Act of 1934 Emergent Health Corp 20104 Valley Forge Circle King of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 10 GENERAL FORM FOR REGISTRATION OF SECURITIES OF SMALL BUSINESS ISSUERS Under Section 12(b) or 12(g) of the Securities Exchange Act of 1934 Emergent Health Corp 20104 Valley Forge Circle King of Prussia, PA 19406 Phone: 866-427-6143 Transfer Agent Old Monmouth Stock Transfer Co.

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista